DGX
Companies
Nyse American
Quest Diagnostics Inc.
Health Care
$179.77
+$30.33 (+20.30%)
Price Chart
Overview
About DGX
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Market Cap
$15.8B
Volume
214.4M
Avg. Volume
227.0M
P/E Ratio
16.741802
Dividend Yield
2.00%
Employees
36.5K
Company Information
Exchange
Nyse American
Sector
Health Care
Industry
Diagnostics & Research
Risk & Correlation Analysis
Market Correlation
0.42
Low Correlation
Volatility
Medium (0.21)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, DGX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$15.8B
Volume214.4M
P/E Ratio16.74
Dividend Yield2.00%
Important Dates
Next Dividend
April 21, 2025Next Earnings
April 21, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025